DTL
KRYS icon

Dynamic Technology Lab’s Krystal Biotech KRYS Stock Holding History

Dynamic Technology Lab’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,570
Closed -$414K – 1233
2023
Q3 		$414K Sell
3,570
-490
-12% -$59.8K 0.04% 548
2023
Q2 		$477K Buy
+4,060
New +$415K 0.06% 519

Other funds holding KRYS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Dynamic Technology Lab's KRYS Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Krystal Biotech (KRYS) in Q4 2023, closing a stake of 3,570 shares — an estimated $414K sold.

Dynamic Technology Lab first reported a position in KRYS in Q2 2023 and held it in 2 quarters. The position peaked at $477K in Q2 2023. 194 funds tracked by Wall St. Rank hold KRYS as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Krystal Biotech position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 3,570 Krystal Biotech shares in Q4 2023, an estimated $414K.
  • Dynamic Technology Lab first reported a position in Krystal Biotech in Q2 2023 and held it in 2 quarters.
  • Dynamic Technology Lab's Krystal Biotech position peaked at $477K in Q2 2023.
  • 194 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.